NCT01935479View on ClinicalTrials.gov

A Phase I Study of AK159 in Healthy Postmenopausal Women

PHASE1CompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Osteoporosis
Interventions
DRUG

AK159

transdermal administration of teriparatide acetate

DRUG

MN-10-T

subcutaneous administration of teriparatide acetate

DRUG

Placebo

Placebo AK159

Trial Locations (3)

Unknown

Fukuoka

Kumamoto

Sumida City

All Listed Sponsors
lead

Asahi Kasei Pharma Corporation

INDUSTRY

NCT01935479 - A Phase I Study of AK159 in Healthy Postmenopausal Women | Biotech Hunter | Biotech Hunter